Newsroom | 2154 results

GLASGOW, Scotland--(BUSINESS WIRE)--Neuranics, the Scotland-based global leader in magnetic-sensing solutions, today announced a breakthrough year defined by substantial technical innovation, global recognition, and the progression of its full technology stack from advanced research to commercial-ready deployment. Strengthened by a strategic investment round earlier in the year, Neuranics is now positioned to drive large-scale commercialisation and has opened licensing and co-development discus...

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced elluminate AI agents – intelligence in action across the entire elluminate ecosystem. First previewed at the company’s ENGAGE conference in October, the AI agents are embedded within four key pillars of the elluminate Clinical Data Cloud®: Data Mapping, Data Review, RBQM, and Study Operations. With governed data, explainable intelligence, and human supervision, the comp...

LONDON--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the UK and Ireland launch of Owlet360™, a new subscription service designed to give parents a deeper, personalized understanding of their baby’s sleep and daily trends. Built for families using medically-certified Dream Sock® and Dream Sight™ or Owlet Cam® 2, Owlet360 leverages Owlet’s unique infant dataset to deliver actionable insights and context, helping pare...

SAN FRANCISCO--(BUSINESS WIRE)--OpenVPN, the number one-ranked business VPN and ZTNA solution on G2, announced today a strategic partnership with iVALT, the leader in mobile-centric, PKI-anchored human identity. Together, the companies are introducing a breakthrough in secure remote access: one-click VPN login backed by human-bound PKI identity, eliminating passwords, stopping social-engineering attacks, and defending against the growing surge of AI deepfake impersonation. Under the new partner...

HOUSTON--(BUSINESS WIRE)--Artella Solutions Inc. announces a multi-year partnership to deliver ambulatory cardiac monitoring solutions with VivaLink....

JERSEY CITY, N.J.--(BUSINESS WIRE)--Plynk®, the app designed to simplify the investing process and empower users with intuitive tools, is celebrating a successful year of expanded features that enhance investors’ experiences. Plynk’s AI-powered news feature, provided by Pebble, a fintech focused on turning complexity into clarity, scans, summarizes, and delivers current insights tailored to a user’s stock portfolio and watchlist so they can stay informed without sifting through endless headline...

BARCELONA, Spain--(BUSINESS WIRE)--REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker innovation, announced today the presentation of seven studies at the upcoming San Antonio Breast Cancer Symposium (SABCS) 2025, held December 9–12 in San Antonio, Texas. These abstracts showcase the growing clinical utility and innovation of the company’s proprietary RNA platform and underscore REVEAL GENOMICS’ commitment to improving outcom...

EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning platform created with healthcare professionals (HCPs) and for healthcare professionals. The platform is now available in Belgium, Germany, the Kingdom of Saudi Arabia, the Netherlands, and Spain with further EMEA country launches planned for 2026. Guided directly by H...

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermo-acoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced new results from its 2025 TAEUS Liver device feasibility study demonstrating that TAEUS’ thermo-acoustic fat fraction (TAFF) measurement closely tracks the MRI-PDFF gold standard at critical liver fat fraction (LFF) thresholds of 12-17% and 20-22%. These threshold...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long-term strategy, including the pathway for expanding Masimo’s position as a global leader in patient monitoring, the Company’s multi-year pipeline, and a clear roadmap to deliver durable revenue growth, margin expansion and increased cash flow. Masimo also provided a detailed look at each of its gro...